abl kinase inhibition: disease modifying strategy for parkinson’s disease
Published 2 years ago • 779 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
4:55
parkinson's disease modification through c-abl inhibition
-
18:37
disease modification of parkinson's disease through oral kinase inhibitor therapy
-
49:21
inhibikase therapeutics: developing therapies to reverse parkinson’s disease
-
20:02
inhibikase: innovating kinase inhibitor therapeutics for neurodegenerative diseases
-
2:17
analysis of the therapeutic potential of c-abl inhibition in parkinson's disease & msa
-
9:49
inhibikase therapeutics talks focus on developing therapeutics for parkinson's and related disorders
-
2:05
alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in parkinson’s disease
-
59:56
inhibikase 2023 virtual r&d event
-
2:31
phase ii study of risvodetinib in parkinson's disease
-
6:04
nasdaq tradetalks: inhibikase therapeutics
-
1:19
ikt-148009 - addressing loss of function in parkinson's patients
-
2:22
enrolling treatment-naive patients in parkinson’s disease clinical trials
-
24:10
inhibikase therapeutics, inc @ sachs nif
-
23:53
inhibikase therapeutics, inc. (nasdaq: ikt) webcast | planet microcap showcase: vegas 2023
-
41:19
inhibikase therapeutics $ikt ceo discusses parkinson's opportunities and potential of the company!
-
3:42
what is the link between hyperactive innate immunity and neurodegeneration in parkinson’s disease?
-
1:05
ms highlights at aan: btk inhibitors
-
1:01:02
the potential for disease-modifying therapies in parkinson’s disease